Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Expected to Post Q2 2024 Earnings of ($0.26) Per Share
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) – Research analysts at Leerink Partnrs issued their Q2 2024 EPS estimates for shares of Intra-Cellular Therapies in a report released on Sunday, January 21st. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will post earnings per share of ($0.26) for the quarter. The consensus estimate […]